skip to main content

Chemistry, part 2

Content language

Contact us: CRM@email.irandoc.ac.ir

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > sulfur molecular entity > organosulfur compound > organic sulfide > thiopurine > 2-(4-morpholinyl)-n-[(4-nitro-1h-benzimidazol-2-yl)methyl]-9-(3-thiophenyl)-6-purinamine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organonitrogen heterocyclic compound > imidazopyrimidine > purines > thiopurine > 2-(4-morpholinyl)-n-[(4-nitro-1h-benzimidazol-2-yl)methyl]-9-(3-thiophenyl)-6-purinamine
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > imidazopyrimidine > purines > thiopurine > 2-(4-morpholinyl)-n-[(4-nitro-1h-benzimidazol-2-yl)methyl]-9-(3-thiophenyl)-6-purinamine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > imidazopyrimidine > purines > thiopurine > 2-(4-morpholinyl)-n-[(4-nitro-1h-benzimidazol-2-yl)methyl]-9-(3-thiophenyl)-6-purinamine
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > imidazopyrimidine > purines > thiopurine > 2-(4-morpholinyl)-n-[(4-nitro-1h-benzimidazol-2-yl)methyl]-9-(3-thiophenyl)-6-purinamine
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organic heteropolycyclic compound > organic heterobicyclic compound > imidazopyrimidine > purines > thiopurine > 2-(4-morpholinyl)-n-[(4-nitro-1h-benzimidazol-2-yl)methyl]-9-(3-thiophenyl)-6-purinamine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteropolycyclic compound > organic heterobicyclic compound > imidazopyrimidine > purines > thiopurine > 2-(4-morpholinyl)-n-[(4-nitro-1h-benzimidazol-2-yl)methyl]-9-(3-thiophenyl)-6-purinamine
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteropolycyclic compound > organic heterobicyclic compound > imidazopyrimidine > purines > thiopurine > 2-(4-morpholinyl)-n-[(4-nitro-1h-benzimidazol-2-yl)methyl]-9-(3-thiophenyl)-6-purinamine
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic aromatic compound > heteroarene > imidazopyrimidine > purines > thiopurine > 2-(4-morpholinyl)-n-[(4-nitro-1h-benzimidazol-2-yl)methyl]-9-(3-thiophenyl)-6-purinamine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic aromatic compound > heteroarene > imidazopyrimidine > purines > thiopurine > 2-(4-morpholinyl)-n-[(4-nitro-1h-benzimidazol-2-yl)methyl]-9-(3-thiophenyl)-6-purinamine
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic aromatic compound > heteroarene > imidazopyrimidine > purines > thiopurine > 2-(4-morpholinyl)-n-[(4-nitro-1h-benzimidazol-2-yl)methyl]-9-(3-thiophenyl)-6-purinamine
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > heteroarene > imidazopyrimidine > purines > thiopurine > 2-(4-morpholinyl)-n-[(4-nitro-1h-benzimidazol-2-yl)methyl]-9-(3-thiophenyl)-6-purinamine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > heteroarene > imidazopyrimidine > purines > thiopurine > 2-(4-morpholinyl)-n-[(4-nitro-1h-benzimidazol-2-yl)methyl]-9-(3-thiophenyl)-6-purinamine
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > heteroarene > imidazopyrimidine > purines > thiopurine > 2-(4-morpholinyl)-n-[(4-nitro-1h-benzimidazol-2-yl)methyl]-9-(3-thiophenyl)-6-purinamine

Preferred term

2-(4-morpholinyl)-n-[(4-nitro-1h-benzimidazol-2-yl)methyl]-9-(3-thiophenyl)-6-purinamine  

Type

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

Broader concept

charge

  • 0

formula

  • C21H19N9O3S

inchi

  • InChI=1S/C21H19N9O3S/c31-30(32)15-3-1-2-14-17(15)25-16(24-14)10-22-19-18-20(29(12-23-18)13-4-9-34-11-13)27-21(26-19)28-5-7-33-8-6-28/h1-4,9,11-12H,5-8,10H2,(H,24,25)(H,22,26,27)

inchikey

  • FLKHSCQMBSUMSH-UHFFFAOYSA-N

mass

  • 477.501

monoisotopicmass

  • 477.13316

smiles

  • C1COCCN1C2=NC3=C(C(=N2)NCC4=NC5=C(N4)C=CC=C5[N+](=O)[O-])N=CN3C6=CSC=C6

subset

  • 2_STAR

In other languages

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:93364

Download this concept:

RDF/XML TURTLE JSON-LD